Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,263 | 80,927 | 178,266 | 305,744 | 233,351 |
| Receivables | 10,402 | 15,389 | 28,346 | 23,790 | 24,672 |
| Inventories | 14,431 | 10,206 | 14,159 | 9,862 | 1,404 |
| Other current assets | 1,165 | 0 | 0 | 0 | 0 |
| TOTAL | $90,371 | $117,022 | $230,432 | $346,462 | $266,150 |
| Non-Current Assets | |||||
| PPE Net | 3,260 | 6,505 | 13,020 | 15,066 | 11,923 |
| Investments And Advances | 0 | 0 | 0 | 0 | 17,566 |
| Intangibles | 31,863 | 20,287 | 27,197 | 12,552 | 14,629 |
| Other Non-Current Assets | 18,729 | 23,712 | 23,652 | 22,423 | 23,145 |
| TOTAL | $53,852 | $50,504 | $63,869 | $50,041 | $67,263 |
| Total Assets | $144,223 | $167,526 | $294,301 | $396,503 | $333,413 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,948 | 812 | N/A |
| Accounts payable and accrued liabilities | 65,501 | 73,562 | 97,446 | 90,660 | 45,389 |
| Other current liabilities | 1,718 | 4,980 | 16,917 | N/A | N/A |
| TOTAL | $71,399 | $84,908 | $127,715 | $101,042 | $51,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,962 | 60,856 | 93,142 | 46,564 | 59,814 |
| Deferred Revenues | N/A | N/A | N/A | 2,611 | 0 |
| Other Non-Current Liabilities | 91,364 | 113,692 | 150,757 | 123,143 | 81,299 |
| TOTAL | $74,468 | $81,031 | $116,561 | $69,584 | $84,654 |
| Total Liabilities | $145,867 | $165,939 | $244,276 | $170,626 | $136,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,534 | 19,235 | 8,655 | 6,970 | 6,330 |
| Common Shares | 28 | 15 | 7 | 101 | 95 |
| Retained earnings | -740,867 | -694,870 | -634,233 | -547,463 | -482,760 |
| Other shareholders' equity | -24,381 | -20,957 | 8,304 | 117,203 | 96,661 |
| TOTAL | $-1,644 | $1,587 | $50,025 | $225,877 | $196,999 |
| Total Liabilities And Equity | $144,223 | $167,526 | $294,301 | $396,503 | $333,413 |